Healthcare Services Group director acquires 123 shares

A director's board and committee fees are represented by DSUs that settle in common shares 90 days after Board service ends.

Rhea-AI Filing Summary

Healthcare Services Group director Thomas Gerard Whalen acquired 123 shares on September 30, 2026, through fully vested Deferred Stock Units (DSUs) elected in lieu of cash board and committee fees. The election was made in 2025 for fees earned in 2026. The reported $20.45 per-share figure was the closing price used to calculate the share count. DSUs are settled in common stock 90 days after Board service ends, with further deferral permitted under Code Section 409A. Whalen's reported post-transaction position was 5,480 shares: 1,969 unvested and 3,511 vested DSUs.

Insider Trade Summary 10b5-1

Grant/Award: 123 shares

Grant/Award 1 txn

Insider WHALEN THOMAS GERARD

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	123	$20.45	$3K

Holdings After Transaction: Common Stock — 5,480 shares (Direct)

Footnotes (2)

1. F1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to Director's fees earned in 2026 in compliance with the Issuer's blackout period guidelines. The number of shares represents the quotient of the amount of such fees divided by the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock ninety days following separation of service from the Board. The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.
2. F2. Amount represents 1,969 unvested DSUs and 3,511 vested DSUs.

Key Figures

Shares acquired: 123 shares Closing stock price: $20.45 per share Post-transaction position: 5,480 shares +3 more

6 metrics

Shares acquired 123 shares September 30, 2026; through fully vested DSUs

Closing stock price $20.45 per share Price used to calculate the DSU share count

Post-transaction position 5,480 shares Reported after the transaction

Unvested DSUs 1,969 DSUs Part of the reported post-transaction position

Vested DSUs 3,511 DSUs Part of the reported post-transaction position

DSU settlement period 90 days Following separation of service from the Board

Key Terms

Deferred Stock Units, 2020 Omnibus Incentive Plan, Code Section 409A, blackout period guidelines

4 terms

Deferred Stock Units financial

"fully vested shares of Deferred Stock Units ("DSUs")"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

2020 Omnibus Incentive Plan financial

"under the Issuer's 2020 Omnibus Incentive Plan"

Code Section 409A regulatory

"pursuant to the rules of Code Section 409A"

blackout period guidelines regulatory

"in compliance with the Issuer's blackout period guidelines"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HCSG shares did director Thomas Gerard Whalen acquire?

Thomas Gerard Whalen acquired 123 shares on September 30, 2026, through fully vested DSUs elected instead of cash board and committee fees. The reported $20.45 per-share figure was the closing price used to calculate the share count.

How was the HCSG director's DSU share count calculated?

The 123-share amount represents the fees divided by Healthcare Services Group's closing stock price on the date those fees otherwise would have been paid, rounded up to the nearest whole share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:03 PM Accepted by SEC EDGAR 10/01/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WHALEN THOMAS GERARD

(Last) (First) (Middle)

3220 TILLMAN DR

SUITE 300

(Street)

BENSALEM PENNSYLVANIA 19020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2026		A		123	A	$20.45(1)	5,480(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to Director's fees earned in 2026 in compliance with the Issuer's blackout period guidelines. The number of shares represents the quotient of the amount of such fees divided by the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock ninety days following separation of service from the Board. The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.

2. Amount represents 1,969 unvested DSUs and 3,511 vested DSUs.

Remarks:

	Michael Harrity, by Power of Attorney	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)